Tenet Healthcare (THC) Misses Q4 EPS by 15c, Offers FY15 Guidance

Tenet Healthcare (NYSE: THC) reported Q4 EPS of $1.03, $0.15 worse than the analyst estimate of $1.18. Revenue for the quarter came in at $4.47 billion versus the consensus estimate of $4.34 billion.

Tenet Healthcare Corporation reported Adjusted EBITDA of $646 million for the fourth quarter ended December 31, 2014, an increase of $202 million, or 45.5 percent, compared to $444 million in the fourth quarter of 2013.

Tenet Healthcare sees FY2015 EPS of $1.32-$2.40, may not compare to the consensus of $2.31.

The company confirmed its existing 2015 Outlook for Adjusted EBITDA to be in a range of $2.05 billion to $2.15 billion. For the first quarter ending March 31, 2015, the company expects Adjusted EBITDA of $475 million to $525 million and earnings per share of $0.05 to $0.55 per sha

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
• Boston Scientific (BSX) pipeline strength fuels quarterly earnings beat
• Amphenol (APH) Reports Q1, Announces $2B Share Buyback